Skip to content

Sarcopenia—the progressive, age-related loss of muscle mass and strength—represents a major health challenge whose underlying mechanisms remain only partially understood. Skeletal muscle displays remarkable plasticity: when subjected to a decline in electrical activity—during neuromuscular disease, immobilization, or aging—it triggers a compensatory response aimed at limiting atrophy. Among the mediators of this response is the growth and differentiation factor 5 (GDF5) signaling pathway, known to curb muscle wasting after denervation and to promote reinnervation. The authors hypothesized that the voltage-gated calcium channel CaV1.1, centrally involved in excitation–contraction coupling, might also sense variations in electrical activity and initiate this adaptation.

Using a mouse model of denervation by sciatic nerve transection, the team uncovered a genuine transcriptional switch affecting the channel's β1 subunit (CaVβ1), encoded by the Cacnb1 gene and regulated by the muscle's innervation status. In the healthy adult, muscle constitutively expresses the CaVβ1D isoform. However, when electrical activity is disrupted, an embryonic isoform reappears, termed CaVβ1E, whose induction relies on epigenetic regulation. This isoform is not merely re-expressed: it stimulates downstream GDF5 signaling, thereby counteracting the loss of mass that follows denervation.

The work then establishes a direct link between this pathway and aging. Compared with young muscle, aged muscle expresses reduced amounts of CaVβ1E and exhibits an impaired GDF5-dependent response to denervation. Conversely, experimental overexpression of CaVβ1E improves the preservation of mass in aging rodent muscle, precisely by increasing GDF5 expression. The CaVβ1E/GDF5 axis thus emerges as a determinant of the muscle's capacity to compensate for atrophy, a capacity that deteriorates with age.

The translational significance of these findings lies in the identification of an analogous human isoform, hCaVβ1E, expressed in adult muscle. The authors report a correlation between its expression level in human muscles and the age-associated decline in muscle mass, suggesting that the mechanism characterized in mice may be conserved in humans. These findings thus reveal a previously unknown link, independent of excitation–contraction coupling, between a protein that senses electrical activity and the adaptation of adult muscle to atrophy. They lead the authors to propose that strategies targeting CaVβ1E or GDF5 could prove effective in reducing muscle mass loss during aging.